TI
NVO

Trexquant Investment’s Novo Nordisk NVO Stock Holding History

Trexquant Investment’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.8M Buy
1,227,405
+244,632
+25% +$10.5M 0.35% 35
2026
Q1 		$36.1M Buy
982,773
+785,722
+399% +$37.2M 0.26% 56
2025
Q4 		$10M Buy
+197,051
New +$10.1M 0.09% 309
2025
Q3 		– Sell
-93,598
Closed -$6.46M – 1808
2025
Q2 		$6.46M Sell
93,598
-284,140
-75% -$19.3M 0.07% 427
2025
Q1 		$26.2M Buy
377,738
+145,492
+63% +$12M 0.31% 49
2024
Q4 		$20M Buy
232,246
+62,267
+37% +$6.73M 0.23% 79
2024
Q3 		$20.2M Buy
169,979
+163,951
+2,720% +$21.9M 0.26% 79
2024
Q2 		$860K Sell
6,028
-101,159
-94% -$13.4M 0.01% 1055
2024
Q1 		$13.8M Sell
107,187
-153,832
-59% -$18.3M 0.27% 63
2023
Q4 		$27M Buy
+261,019
New +$25.8M 0.61% 12
2023
Q3 		– Sell
-12,838
Closed -$1.04M – 1712
2023
Q2 		$1.04M Buy
+12,838
New +$1.05M 0.03% 741
2023
Q1 		– Sell
-74,114
Closed -$5.02M – 1664
2022
Q4 		$5.02M Sell
74,114
-113,284
-60% -$6.64M 0.14% 189
2022
Q3 		$9.34M Buy
187,398
+104,460
+126% +$5.6M 0.33% 64
2022
Q2 		$4.62M Buy
82,938
+29,140
+54% +$1.62M 0.21% 106
2022
Q1 		$2.99M Sell
53,798
-49,322
-48% -$2.53M 0.14% 181
2021
Q4 		$5.78M Buy
+103,120
New +$5.59M 0.36% 52
2021
Q1 		– Sell
-30,068
Closed -$1.05M – 1359
2020
Q4 		$1.05M Buy
+30,068
New +$1.04M 0.11% 248
2020
Q2 		– Sell
-39,562
Closed -$1.19M – 1366
2020
Q1 		$1.19M Buy
+39,562
New +$1.18M 0.09% 362
2018
Q4 		– Sell
-35,086
Closed -$827K – 1231
2018
Q3 		$827K Buy
+35,086
New +$856K 0.06% 401
2016
Q4 		– Sell
-33,600
Closed -$699K – 1092
2016
Q3 		$699K Buy
33,600
+800
+2% +$19.8K 0.16% 209
2016
Q2 		$882K Sell
32,800
-35,828
-52% -$983K 0.12% 272
2016
Q1 		$1.86M Buy
+68,628
New +$1.84M 0.22% 128

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Trexquant Investment's NVO Position: Q2 2026 in Review

Trexquant Investment increased its Novo Nordisk (NVO) stake by 25% in Q2 2026, buying an estimated $10.5M and bringing the position to 1,227,405 shares worth $58.8M. The position accounts for 0.35% of the portfolio, ranked #35.

Trexquant Investment first reported a position in NVO in Q1 2016 and has held it in 22 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Trexquant Investment held 1,227,405 shares of Novo Nordisk worth $58.8M as of Q2 2026.
  • Trexquant Investment bought 244,632 Novo Nordisk shares in Q2 2026, an estimated $10.5M.
  • Novo Nordisk made up 0.35% of Trexquant Investment's portfolio in Q2 2026, its #35 holding.
  • Trexquant Investment first reported a position in Novo Nordisk in Q1 2016 and has held it in 22 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.